PUMA, ADRIANA
 Distribuzione geografica
Continente #
NA - Nord America 278
EU - Europa 145
AS - Asia 62
AF - Africa 51
SA - Sud America 1
Totale 537
Nazione #
US - Stati Uniti d'America 276
IT - Italia 43
IE - Irlanda 42
CI - Costa d'Avorio 36
CN - Cina 24
SG - Singapore 24
DE - Germania 17
SN - Senegal 15
RU - Federazione Russa 8
CZ - Repubblica Ceca 6
GB - Regno Unito 6
SE - Svezia 5
BE - Belgio 4
IN - India 4
NO - Norvegia 3
UZ - Uzbekistan 3
CA - Canada 2
CH - Svizzera 2
FI - Finlandia 2
HK - Hong Kong 2
PL - Polonia 2
TR - Turchia 2
BR - Brasile 1
ES - Italia 1
FR - Francia 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 537
Città #
Chandler 97
Dublin 42
Chicago 39
Abidjan 36
Singapore 20
Ashburn 18
Dakar 15
Catania 14
Boardman 12
Andover 11
Cambridge 11
Lawrence 11
Grafing 8
Brno 6
Des Moines 6
Munich 6
Los Angeles 5
Brussels 4
Nanjing 4
Pune 4
Wilmington 4
Beijing 3
Edinburgh 3
Fantina 3
Hanover 3
Oslo 3
Saint Petersburg 3
Aci Catena 2
Helsinki 2
Houston 2
Jiaxing 2
London 2
Palermo 2
Santa Venerina 2
Seattle 2
Athens 1
Bratislava 1
Fairfield 1
Grosseto 1
Hebei 1
Kocaeli 1
Luxembourg 1
Madrid 1
Manchester 1
Mascali 1
Montreal 1
Moscow 1
Nanchang 1
Polska 1
Redmond 1
Redwood City 1
São Paulo 1
Tel Aviv 1
Tokyo 1
Toronto 1
Woodbridge 1
Zhengzhou 1
Totale 429
Nome #
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 61
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 60
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 58
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 56
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 55
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 54
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 51
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 47
Opportunities and challenges of liquid biopsy in thyroid cancer 44
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 42
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 40
Totale 568
Categoria #
all - tutte 2.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 1 1 2 0 0 1 0 1 7 11
2020/202128 2 0 2 5 7 0 0 1 9 1 0 1
2021/202278 0 13 5 1 19 2 11 3 2 0 2 20
2022/2023233 12 23 7 33 11 37 0 49 44 3 10 4
2023/2024119 6 21 1 1 4 40 0 9 0 7 23 7
2024/202572 8 62 2 0 0 0 0 0 0 0 0 0
Totale 568